ARA-290: structure, nomenclature and handling

The parent is erythropoietin, a 165-residue glycoprotein whose mass is dominated by attached carbohydrate. Its fold is a four-helix bundle, and the helices are conventionally labelled A through D. ARA-290 corresponds to a stretch of the B helix — hence the description of it in the literature as a helix B surface peptide.

The fragment itself is eleven residues, with a molecular weight of approximately 1,257 daltons. It carries no carbohydrate: glycosylation is a property of the expressed parent and cannot be reproduced by chemical synthesis, so the fragment is a bare peptide chain in a way the parent never is. That is the largest structural difference between them, since much of what defines erythropoietin as a molecule resides in the sugars rather than the sequence.

The sequence begins with a glutamine-derived residue and includes glutamate, arginine, leucine, alanine, asparagine and serine — an acidic and polar composition with a single basic residue. There is no cysteine, so unlike its parent the fragment carries no disulfide architecture.

It is characterized against a heteromeric receptor comprising the erythropoietin receptor together with the beta common receptor subunit, rather than against the classical erythropoietin receptor alone. That distinction — a receptor complex of two different subunits, not the homodimer the parent engages — is the reason the fragment is catalogued as a separate entity rather than as a piece of erythropoietin.

The material is catalogued as ARA-290 and under the international non-proprietary name cibinetide. It also appears as helix B surface peptide, abbreviated HBSP, and occasionally as pyroglutamate helix B surface peptide. As with most synthetic peptides, it is typically isolated as an acetate salt, which affects the mass weighed out without altering identity.

The parent appears as erythropoietin, EPO and epoetin. Those names belong to the glycoprotein — a different class of product entirely, expressed rather than synthesized and heavier by a factor of more than twenty. Listings that conflate them are imprecise in a way the stated mass resolves immediately.

Mass spectrometry confirms the intact molecular mass near 1,257 daltons and separates the fragment from its parent by an enormous margin.

The compound-specific identity question concerns the amino terminus. A glutamine at the start of a peptide chain cyclizes readily to pyroglutamate, an internal ring closure that releases ammonia and leaves the molecule lighter by a defined seventeen daltons. For this sequence the cyclized form is the intended one, so the theoretical mass on the certificate should reflect it — and a batch measuring seventeen daltons heavier indicates the open-chain form rather than the target. It is a check that takes seconds once you know to make it and is invisible if you do not.

High-performance liquid chromatography resolves the main peak from related substances and yields the purity figure. An eleven-residue synthesis produces the familiar deletion sequences. The sequence-specific consideration is the asparagine, which deamidates to aspartate — about one dalton, and a charge change too, so it separates chromatographically as well as shifting mass.

HEEZ Research supplies ARA-290 in a single format: a 10 mg lyophilized vial. There is no second strength in the current catalogue, so the format decision that arises with two-size products does not apply here.

The material is supplied as a lyophilized powder. Freeze-drying removes water and leaves the peptide as a solid, markedly more stable than the same peptide in solution, and stable enough at ambient temperature to ship without refrigeration in transit.

Reconstitution converts the dried cake into a working solution, and it is a standard laboratory step rather than a product specification. Which solvent is used, and at what final concentration, is determined by the protocol in force at the receiving facility.

What HEEZ specifies is the contents of the vial: lyophilized ARA-290 in a single 10 mg format, stated on the label and on the batch certificate of analysis. Where a protocol is expressed in molar rather than mass terms, the additional figure it needs is the molecular weight, which the certificate records for the batch supplied.

The composition is net acidic, with two acidic side chains against a single basic one. A peptide is least soluble near its isoelectric point, and for an acidic sequence that point sits low — so the mildly acidic media suiting the basic sequences elsewhere in this catalogue are the wrong default here. At eleven residues the chain dissolves readily in a suitable medium, and vigorous agitation is unnecessary.

Sealed lyophilized ARA-290 is ambient-stable for the duration of transit, so no cold chain or insulated packaging is required for shipping. On receipt the vial goes to refrigeration and is kept out of direct light.

Reconstituted material is held refrigerated and used within the window the receiving facility's protocols specify, and repeated freeze-thaw cycling is avoided. Solutions are treated as short-lived relative to the lyophilized form.

The asparagine is the residue that governs storage discipline here. Deamidation proceeds slowly in solution and faster at alkaline pH, so a peptide that was clean at manufacture can accumulate the deamidated form while sitting in a tube — a degradation route that operates after the certificate was issued rather than before it. Keeping the material dry until needed and making solutions up fresh is the mitigation. The absence of cysteine and methionine removes the common oxidation routes entirely.

The certificate records what an independent facility measured for one specific batch. Its value lies in being batch-specific, so the first check is that the lot number on the document matches the vial in hand.

The identity section compares observed molecular mass against a stated theoretical mass near 1,257 daltons. Note which N-terminal form that theoretical figure describes: the seventeen-dalton difference between the cyclized and open-chain termini is the most informative single check available on this compound.

The purity figure is the HPLC main-peak area as a percentage of total peak area, and the attached chromatogram shows how it was arrived at. A peak close to the main one is consistent with the deamidated form, which is worth distinguishing from a synthesis by-product because the two have different causes and different trajectories over time.

Peptide content, or net peptide content, is sometimes reported separately. It accounts for counter-ions and residual water, and it is the figure determining how much actual peptide a nominal 10 mg represents.